The results showed that virtually all the APS patients, either primary (PAPS) or secondary (SAPS), as well as the subjects with pregnancy morbidity showed increased serum levels of HMGB1, as compared to healthy women, as revealed by densitometric analysis (Figure 1(b)). This evidence concerns the gene HMGB1 and autoimmune polyendocrinopathy.